BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35604378)

  • 1. Acute Bilateral Vision Loss Following Unilateral Optic Nerve Sheath Fenestration.
    Levergood N; Park JK; Campbell B; Lee HBH
    Ophthalmic Plast Reconstr Surg; 2022 Nov-Dec 01; 38(6):e165-e166. PubMed ID: 35604378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of Optic Nerve Sheath Fenestration as a Treatment for Idiopathic Intracranial Hypertension.
    Gilbert AL; Chwalisz B; Mallery R
    Semin Ophthalmol; 2018; 33(1):36-41. PubMed ID: 29420144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach.
    Malik AI; Xu J; Lee AG
    Orbit; 2022 Aug; 41(4):413-421. PubMed ID: 33588671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of visual loss in pseudotumor cerebri associated with uremia.
    Guy J; Johnston PK; Corbett JJ; Day AL; Glaser JS
    Neurology; 1990 Jan; 40(1):28-32. PubMed ID: 2296378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic nerve sheath fenestration for vision preservation in idiopathic intracranial hypertension.
    Agarwal MR; Yoo JH
    Neurosurg Focus; 2007; 23(5):E7. PubMed ID: 18004969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient vision loss after optic nerve sheath fenestration.
    Al Othman B; Raabe J; Malik A; Li H; Kini A; Lee AG
    Orbit; 2020 Jun; 39(3):217-220. PubMed ID: 31537140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Magnetic Resonance Imaging Characteristics of Postfenestration Optic Nerve Sheath Pseudomeningoceles.
    Rafailov L; Rubinstein D; Wladis EJ; Mirani N; Frohman LP; Langer PD; Turbin RE
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):159-164. PubMed ID: 30134388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral and highly asymmetric papilledema in pseudotumor cerebri.
    Lepore FE
    Neurology; 1992 Mar; 42(3 Pt 1):676-8. PubMed ID: 1549237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdisciplinary Protocol for the Management of Vision-Threatening Papilledema.
    Brady T; Vegunta S; Crum AV; Marx D; Patel BCK; Seay MD; Schmidt RH; Warner JEA; Digre KB; Katz BJ
    J Neuroophthalmol; 2022 Dec; 42(4):495-501. PubMed ID: 35439211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting.
    McCluskey PJ; Lam D; Ang T; Todd MJ; Halmágyi GM
    Clin Exp Ophthalmol; 2023; 51(4):349-358. PubMed ID: 36754636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual recovery after unilateral optic nerve sheath fenestration for pseudotumor cerebri syndrome.
    Dai YL; Ramsey DJ; Athappilly GK; Tucker SM
    Orbit; 2023 Aug; 42(4):397-403. PubMed ID: 36069075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic nerve sheath fenestration for the treatment of papilledema secondary to cerebral venous thrombosis.
    Murdock J; Tzu JH; Schatz NJ; Lee WW
    J Neuroophthalmol; 2014 Mar; 34(1):67-9. PubMed ID: 24343230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Response.
    Scofield-Kaplan SM; Patel KG; Jones FR; Hogan RN
    J Neuroophthalmol; 2021 Mar; 41(1):135-136. PubMed ID: 32358437
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Comment.
    Margolin E
    J Neuroophthalmol; 2021 Mar; 41(1):135. PubMed ID: 32358434
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign intracranial hypertension: visual loss and optic nerve sheath fenestration.
    Knight RS; Fielder AR; Firth JL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):243-50. PubMed ID: 3958737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic Optic Nerve Sheath Fenestration for Treatment of Papilledema Secondary to Intracranial Venous Hypertension: Report of Two Cases.
    Tirakotai W; Masaya-Anon P; Suwansanya J; Sitthimongkon U; Roongpuvapaht B
    J Med Assoc Thai; 2016 Jun; 99 Suppl 3():S141-6. PubMed ID: 29901363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of optic nerve edema and improved visual function after optic nerve sheath fenestration in a patient with osteopetrosis.
    Allen RC; Nerad JA; Kattah JC; Lee AG
    Am J Ophthalmol; 2006 May; 141(5):945-7. PubMed ID: 16678513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion.
    Fonseca PL; Rigamonti D; Miller NR; Subramanian PS
    Br J Ophthalmol; 2014 Oct; 98(10):1360-3. PubMed ID: 24820047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
    Wilkes BN; Siatkowski RM
    J Neuroophthalmol; 2009 Dec; 29(4):281-3. PubMed ID: 19952899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure.
    Liu GT; Volpe NJ; Schatz NJ; Galetta SL; Farrar JT; Raps EC
    Am J Ophthalmol; 1996 Jul; 122(1):129-31. PubMed ID: 8659591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.